Extended Dissociation Case’s Multiple Benzodiazepine Changes Did Not Establish a Single-Drug Response

Written by

in

A complex psychiatric case included lorazepam followed by diazepam alongside several other changes. Its course cannot be reduced to a controlled benzodiazepine treatment result.

The reported sequence

A young man with autism and obsessive–compulsive disorder developed anxiety, agitation, reduced speech, and unusual beliefs. Investigations did not provide a straightforward medical explanation.

Lorazepam and quetiapine were used without an early clear resolution. Later changes included diazepam, antipsychotic substitution, and antidepressant treatment. The evolving diagnostic interpretation concerned an extended dissociative presentation.

Why attribution is difficult

Symptoms, medicines, environment, and observation changed over time. Sequential prescribing does not establish that a switch between benzodiazepines caused improvement or deterioration.

The case also does not validate a medication-response test distinguishing dissociation, psychosis, and catatonia. A forensic account should preserve phenomenology, baseline history, examination, and the exact treatment sequence. The report supplies a clinical narrative and diagnostic uncertainty, not a response probability, safe dose conversion, or proof that one drug explains the entire presentation.

Source paper

Original analysis of the supplied journal article, identified as PMC8110420.

Related research

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *